PET in Breast Cancer Receiving Neoadjuvant Chemotherapy
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: docetaxel (75 mg/m2) and doxorubicin (50 mg/m2)
Sponsor: Seoul National University Hospital